Omeros Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Omeros Corporation's estimated annual revenue is currently $47.9M per year.
- Omeros Corporation received $210.0M in venture funding in November 2018.
- Omeros Corporation's estimated revenue per employee is $203,809
- Omeros Corporation's total funding is $965.4M.
Employee Data
- Omeros Corporation has 235 Employees.
- Omeros Corporation grew their employee count by 0% last year.
Omeros Corporation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 200% | N/A | N/A |
#2 | $1.1M | 7 | -36% | N/A | N/A |
#3 | $4.8M | 31 | 19% | N/A | N/A |
#4 | $1.3M | 17 | -23% | N/A | N/A |
#5 | $31.6M | 163 | 3% | $30.2M | N/A |
#6 | $1.9M | 12 | 0% | N/A | N/A |
#7 | $4.2M | 27 | -16% | N/A | N/A |
#8 | $2.5M | 16 | -27% | N/A | N/A |
#9 | $0.9M | 6 | 0% | N/A | N/A |
#10 | $2.8M | 18 | 0% | N/A | N/A |
What Is Omeros Corporation?
Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
keywords:Biotechnology,E-Commerce,Healthcare,Human Resources Hr,Marketing,Pharmaceuticals$965.4M
Total Funding
235
Number of Employees
$47.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Omeros Corporation News
Omeros Announces Journal of Clinical Oncology Publication Detailing Pivotal ... Omeros Corporation (Nasdaq: OMER) today announced the online...
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced the online publication of a manuscript detailing the results of...
Analysts who follow Omeros Corporation (OMER) on average expect it to add 195.58% over the next twelve months. Those same analysts give the...
Omeros Corporation (OMER) have moved lower over the course of the past week revealing negative downward near-term momentum for the ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $82.1M | 235 | 3% | $41.4M |
#2 | $65.9M | 236 | 12% | N/A |
#3 | $71.7M | 236 | 6% | N/A |
#4 | $46.9M | 237 | N/A | N/A |
#5 | $75.6M | 237 | -14% | N/A |
Omeros Corporation Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2006-09-08 | $Undisclosed | Undisclosed | ARCH Venture Partners, Aravis Venture | Article |
2007-01-12 | $9.0M | Undisclosed | Article | |
2007-02-13 | $63.0M | E | Multiple | Article |
2008-09-25 | $20.0M | Undisclosed | BlueCrest Capital Finance | Article |
2010-07-30 | $40.0M | Undisclosed | Reedland Capital Partners | Article |
2010-10-26 | $20.0M | Undisclosed | Vulcan Capital | Article |
2012-06-27 | $34.5M | Undisclosed | Cowen and Company LLC , Deutsche Bank Securities Inc | Article |
2013-05-10 | $16.2M | Undisclosed | RA Capital Management | Article |
2014-03-06 | $32.0M | Undisclosed | Article | |
2014-03-17 | $35.0M | Undisclosed | Cowen and Company, LLC | Article |
2014-03-20 | $40.2M | Undisclosed | Cowen and Company, LLC | Article |
2015-01-29 | $Undisclosed | Undisclosed | Cowen and Company, LLC | Article |
2015-02-05 | $79.1M | Undisclosed | Cowen and Company, LLC | Article |
2016-01-07 | $70.0M | Undisclosed | Oxford Finance | Article |
2016-05-18 | $20.0M | Undisclosed | Oxford Finance LLC | Article |
2016-08-12 | $40.0M | Undisclosed | Cantor Fitzgerald & Co | Article |
2016-10-28 | $125.0M | Undisclosed | CRG LP | Article |
2017-08-23 | $78.5M | Undisclosed | Cantor Fitzgerald & Co | Article |
2018-11-09 | $210.0M | Undisclosed | Cantor Fitzgerald & Co | Article |